Sergio Fazio works in General / Preventive / Lipids affiliated with Oregon Health & Science University.
Sergio Fazio, MD, PhD, is Vice President and Scientific Council Chair for Cardiometabolic Diseases at Regeneron Pharmaceuticals. He previously served as the William and Sonja Connor Endowed Chair and Professor of Preventive Cardiology at Oregon Health & Science University, where he directed the Center for Preventive Cardiology. His research centers on lipoproteins, cardiovascular risk factors, atherosclerosis, and metabolic diseases.
286 pubs · 16,912 cites · h-index 51
MD
University of Rome La Sapienza
1983
PhD
University of Siena
1990
Regeneron Pharmaceuticals
2018 - Present
Oregon Health & Science University
2014 - 2018
Vanderbilt University
2011 - 2014
Vanderbilt University
2002 - 2011